METHODS
We performed a survey by making face-to-face contact with 318 physicians, of whom 285 were GNs and 33 were multiple sclerosis specialists (MSSs), from 22 cities. The study was conducted according to the Declaration of Helsinki. Informed consent was obtained from all respondents. With this survey of 36 questions, we asked questions on factors such as pregnancy, use of vitamin D, and presence of brain atrophy, which influence neurologists when they are diagnosing and treating MS. For example, the 16 th , 17 th , and 18 th questions of the survey are "In your clinical practice, do you think that vitamin D deficiency affects the course of MS?"; "Which of the following statements do you think are more applicable regarding the relationship between MS and vitamin D levels?"; and "Would you initiate vitamin D treatment when you detect low vitamin D levels in MS patients?", respectively. From these questions, we examined the approaches of physicians regarding vitamin D use and any differences therein; with the 28 th and 29 th questions, i.e., "Do you think that brain atrophy is a measurable parameter?" and "Is brain atrophy a parameter that determines your choice of treatment in your clinical practice?", we intended to find out whether brain atrophy influenced the treatment preferences of physicians.
Statistical Analysis
Qualrate® (GfK; Istanbul, Turkey), an online software, was used to collect study data. With this software, data entered by physicians are instantaneously registered in the database and graphs can be simultaneously seen with a macro. The statistical analysis of collected data was performed using Statistical Package for the Social Sciences version 21.0 (IBM Corp.; Armonk, NY, USA). The chi-square test was used to compare categorical data. Quantitative data were compared using the Student' s t-test for parametric analyses and the Mann-Whitney U-test for non-parametric analyses. P values of ≤0.05 in the two-sided independent t-test were considered statistically significant.
RESULTS

Differences in Approaches to Pregnancy in MS Patients
The disease course and disability status were observed to be major factors preceding pregnancy decisions in both groups (GNs: 45%, MSSs: 85%; p<0.01). The number of patients' children was a more important factor for GNs than for MSSs in pregnancy decisions (31.2% vs. 18.1%) ( Table 1) .
Differences in Approaches to Cerebrospinal Fluid (CSF) Analysis and Vitamin D Levels
In total, 72.1% of GNs and 75.0% of MSSs answered "Yes" to the question "Do you perform CSF analysis to evaluate the risk of MS in patients with clinically isolated syndrome?", indicating that a comparable proportion of GNs and MSSs chose to perform CSF analysis, with almost three-fourth of all neurologists preferring to perform CSF analysis.
Less than 50% of all neurologists included in the study believed that there was a link between vitamin D levels and MS prognosis, with 42.4% of MSSs and 48.8% of GNs answering "Yes" to the question "In your clinical practice, do you think that vitamin D deficiency affects the course of MS?". On the other hand, 27.0% of GNs and 6.0% of MSSs did not commence vitamin D replacement therapy even in patients with reduced vitamin D levels ( Table 2) ; this difference was statistically significant (p<0.001).
Differences with Regard to Radiological Investigations
General neurologists and MSSs significantly differed in responses to the question "How often do you perform MRI follow-up in a patient who was diagnosed with MS and is clinically stable?". The proportion of GNs performing quarterly magnetic resonance imaging (MRI) monitoring was 4.6%, with no MSSs performing quarterly MRI monitoring. Among GNs, 34.7% requested semi-annual monitoring, while only 9.1% of MSSs requested semi-annual monitoring. The proportions of GNs performing annual and biannual MRI monitoring were 48.4 and 12.3%, respectively, compared with corresponding proportions of 78.8 and 12.1% for MSSs ( Figure 1 ). In conclusion, GNs were observed to perform more frequent MRI monitoring than MSSs (chi-square test, p<0.05). In addition, MRI was quite readily available for MSSs, while GNs had problems in performing MRI. Among GNs, 2.5% described that no MRI instrument was available in their area, and 13.0% were occasionally able to access an MRI facility. No MSSs were unable to access an MRI machine, while only 3% responded "I have occasional access. "
The survey also questioned the approach of clinicians to MRI reports (Figure 2 ) and demonstrated that more MSSs than GNs preferred interpreting MRI reports submitted by radiologists (p<0.05). To the question "Which of the below statement(s) best describe your behavior toward the MRI reports you requested?", 91.6% of GNs responded "I review the radiology report and I' d certainly interpret it myself", while 2.1% of them responded "I rely on the report and do not review. " The proportion of GNs responding "I do not review the radiology report; I interpret it myself" was 9.1% compared with the proportion of 21.2% among MSSs. Furthermore, MSSs performed more frequent follow-ups than GNs on patients who show radiologic activity (94.2% vs 80.3%, chi-square; p<0.05) ( Table 3) .
Evidence of brain atrophy (49.4%) and presence of black holes on performing MRI (42.1%) were the major factors regarding disability progression for MSSs, while these corresponding MRI findings were important for 12.2 and 14.3% of GNs (Table 4) .
Differences in Treatment Approaches
The greatest challenge for MSSs in the management of MS patients was the decision to switch treatment in patients not responding to treatment. This was followed by the choice of treatment at onset and difficulties encountered in diagnosing. Almost half of all physicians believed that treatment efficacy was the most important factor in deciding long-term treatments. Although 27.2% of GNs based their diagnoses on the McDonald criteria, they did not initiate DMTs and waited for the next episode for treatment. During their routine clinical experience, only 25.0% of all neurologists considered brain atrophy as a factor in treatment choice.
In addition, 14.3% of physicians commenced DMTs in radiologically isolated syndrome (RIS) patients. GNs were more inclined to treat RIS patients, although the difference was not statistically significant compared with MSSs (15.1% vs. 6.0%, p=0.17). Although MSSs and GNs considered the same factors when changing treatment, GNs made more rapid decisions in patients with treatment response (p=0.02). Among all neurologists, 31.2% changed treatment only when their patients requested and 12.0% changed treatment when they detected a new lesion on performing MRI.
DISCUSSION
There are many international surveys evaluating the approaches of physicians to MS patients (3, 4, 5) . However, very few of these studies were designed to question differences associated with the level of experience of physicians. Considering this, our study is the first in Turkey to compare the behaviors of GNs and specialist neurologists of a specific disease.
When the approaches of physicians to radiological investigations were examined, GNs referred to MRI reports more frequently than MSSs for diagnosing the disease and monitoring treatment. The fact that MRI findings were requested even in clinically stable patients suggest that abundant expenses are being incurrent by MS patients for radiological investigations in Turkey. According to the OECD data, 119 investigations were performed per 1000 people in Turkey in 2013, making Turkey have highest number of MRI requests (6). In addition, the fact that GNs prescribed MRI more frequently although they had less accessibility to it represents an interesting contrast.
Our study also showed that GNs had more confidence in the reports of radiologists than MSSs. One might argue that the most important reason for this could be the preference specialist physicians to interpret laboratory results themselves, while it is also likely that the lesser time GNs could provide to each patient than MSSs could also account for this result. It can be concluded that inaccurate MRI reports submitted by radiologists with no specific neuroradiology training could result in incorrect treatments in some cases.
From the other results of our survey, it appears that GNs do not monitor their patients frequently enough. It also appears that GNs do not considerably rely on radiological parameters such as black holes and brain atrophy in their patients with progressing disease. These results indicate that not enough emphasis is being placed by GNs on the radiological evidence of MS patients.
Results regarding treatment challenges were also interesting. Overall, one of the greatest challenges for neurologists is the criteria recommended to be followed in commencing and switching treatment. This finding is consistent with a previous study conducted outside Turkey (1). Surprisingly, our study showed that GNs tend to switch treatments in a shorter span of time due to the lack of treatment response in treated patients, although they initiated DMT later. In our study, 15% of GNs responded that they treated their RIS patients, although they initiated treatments to MS patients at a later time. This may be due to the confusion of GNs regarding the clinical relevance of RIS. A study on Scottish neurologists reported similar findings (7) . In this study performed by Lumley et al. Turkish neurologists, another explanation might be that physicians may be erroneously associating MRI findings with clinical findings in their patients. Another reason for the high proportion of neurologists initiating DMTs in RIS patients could be the inadequacy of GMs in evaluating MRI findings.
Furthermore, GNs were observed to not have enough confidence in the presence of brain atrophy and low vitamin D levels. This may be due to the difficulty in accessing and interpreting laboratory investigations.
In conclusion, our study determined that GNs had significant differences in their approaches to MS treatment compared with MSSs. These differences demonstrated by GNs who see many more MS patients than MSSs might have a negative consequence on MS patients. Therefore, it was concluded that country-wide informative training activities regarding the management of MS patients are needed for GNs.
Study Limitations
This was a survey, and physicians were expected to provide responses based on their memories of past experiences. This might have resulted in wrong or inadequate responses to some questions.
